Prothena Corp (PRTA): Net earnings per share growth forecast for next year
Prothena Corporation (PRTA) develops cutting-edge treatments for Parkinson's and Alzheimer's diseases. The company's forward EPS dynamics model illustrates how scientific potential correlates with colossal R&D expenditures and stringent FDA requirements. Meanwhile, the value of -4068.40 serves as the baseline indicator for expected earnings. A stable supply of pure components to laboratories will ensure the company successfully navigates the clinical development stages.
Analytical breakdowns for Prothena Corporation
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Prothena Corporation|PRTA - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Prothena Corporation plc|PRTA - Company Cumulative Debt|Debt to Book Capitalization Ratio Prothena|PRTA - Company Long-Term Loans and Borrowings|Company Short-Term Debt Prothena|Quick Liquidity prothena.com
- earnings and valuation multiples information:
PRTA - Company Net Income|Expected Profit Prothena Corporation|PRTA - Company Value to Net Income|Forward P/E Multiple Prothena Biosciences|PRTA - PEG Multiple|Enterprise Value to EBITDA Ratio Prothena|PRTA - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Prothena|PRTA - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months prothena.com|PRTA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Prothena Corporation
- revenue and sales proceeds data:
Fundamental company analysis:PRTA, Prothena Corp
The metric is calculated as the percentage change in expected earnings per share for the coming year relative to the current period. The stability of this line confirms the issuer's resilience, whereas sharp fluctuations signal an asset revaluation ahead of a cycle shift. For Prothena Corporation (PRTA), the volatility of this metric is driven by a dependence on one-time partner payments and clinical trial outcomes. By analyzing the vector of forward net income expectations, an investor assesses capital burn risks.
Competitor analysis for Prothena Corporation
BIIB (Biogen Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year Neurocrine Corp NBIX|Net earnings per share growth forecast for next year Regencell Bioscience (RGC)|axsome.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year ACAD (ACADIA Pharmaceuticals Inc.)|Earnings growth forecast for next year Xenon Pharmaceuticals Inc. XENE|VKTX: Expected earnings per share growth for next year|Expected earnings per share trend next year SUPN (Supernus Corp)|CPRX: Earnings growth forecast for next year|Expected earnings per share growth for next year denalitherapeutics.com|Net earnings per share growth forecast for next year Harmony Biosciences Holdings, Inc.|Expected net earnings per share growth next year Biohaven Ltd BHVN|Net earnings per share growth forecast for next year Amylyx (AMLX)|TRVI (Trevi Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Praxis Precision Medicines PRAX|AVXL (anavex.com) - Net earnings per share change forecast for next year|CBLL - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Alector, Inc.|Annexon Inc. (ANNX) - Net earnings per share growth forecast for next year|Omeros - Expected earnings per share trend next year|NGNE (Neurogene Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year acimmune.com|Expected earnings per share growth for next year VYGR (Voyager Therapeutics, Inc.)|Projected earnings per share increase next year NMRA|Earnings growth forecast for next year SCLX (Scilex Holding Co.)|Consensus forecast of earnings per share growth for next year Tevogen Bio Inc. (TVGN)|ACOG - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Cognition Therapeutics Inc.|Inhibikase Therapeutics, Inc. (IKT) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year SAVA|Net earnings per share growth forecast for next year Assertio Holdings|Coya - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Vistagen Therapeutics (VTGN)|OVID (ovidrx.com) - Expected earnings per share trend next year|Acumen Pharmaceuticals, Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year CRVO (CervoMed, Inc.)|Alterity Therapeutics Ltd - Earnings growth forecast for next year|CLNN - Earnings growth forecast for next year|pepgen.com (PEPG) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year JUNS|RLMD (Relmada Therapeutics, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year Annovis Bio Inc ANVS|Expected earnings per share growth for next year GRCE (Grace Therapeutics, Inc.)|Earnings growth forecast for next year Firefly Neuro (AIFF)|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|Expected earnings per share trend next year NRSN|RVPH - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year MetaVia Inc|NeurAxis, Inc (NRXS) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year HSDT (Helius Medical Technologies)|Net earnings per share growth forecast for next year Passage Bio Inc.|NEUP: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Minerva Neurosciences, Inc. (NERV)|ATHA - Expected net earnings per share growth next year|Addex Therapeutics, Ltd. - Expected earnings per share growth for next year|Projected earnings per share increase next year ALZN (Alzamend Neuro Inc.)|Cyclerion - Earnings growth forecast for next year|Expected earnings per share trend next year PTIX (Protagenic Therapeutics)|KTTA: Earnings growth forecast for next year|Expected net earnings per share growth next year Cortigent (CRGT)|Net earnings per share growth forecast for next year Avenue Therapeutics, Inc|Projected earnings per share growth rate for next year BCLI (BrainStorm Cell Therapeutics Inc.)|Earnings growth forecast for next year CARA|Earnings growth forecast for next year chromocell.com (CHRO)|Eliem Therapeutics Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year ITCI|Longboard Pharma - Earnings growth forecast for next year|Marinus Pharma (MRNS) - Expected earnings per share growth for next year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year neurobopharma.com (NRBO)|Net earnings per share growth forecast for next year Sage Therapeutics|SNPX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Trevena, Inc (TRVN)|VIGL: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Anew Medical WENA|cerevel.com (CERE) - Expected net earnings per share growth next year
